Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CliniMACS® CD34+ Reagent System for Expanded Access Use

NCT02026934 is registered in ClinicalTrials.gov with Joseph Antin as lead sponsor.

NCT NCT02026934
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02026934 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CliniMACS® CD34+ Reagent System for Expanded Access Use
Lead sponsor
Joseph Antin
Phase
Expanded access
Overall status
No longer available
Start date
March 31, 2013
Completion date
Not reported
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anemia due to disturbance of proliferation and/or differentiation of hematopoietic stem cells, delayed graft function, graft failure, graft-versus-host disease(gvhd)